PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25725D0009CTX quantiferon supplies IDIQ - ADD — Qiagen, LLC

Qiagen, LLC holds $19.5M across 397 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

257-Network Contract Office 17 (36C257)
Awarding office
Qiagen, LLC
Recipient
Estimated value
6550
PSC
NONE
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Qiagen, LLC — $90

Contract facts

NONE
Contract number36C25725D0009
Also listed as36C257-25-D-0009
Agency257-Network Contract Office 17 (36C257)
Awarding office257-Network Contract Office 17 (36C257)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentQiagen, LLC
UEIW2GLKC92ZH73
PSC6550
Related solicitation36C25724Q0640

CTX QUANTIFERON SUPPLIES IDIQ - ADD EO 14398 is a federal NONE award for 257-Network Contract Office 17 (36C257) held by Qiagen, LLC. Estimated value —. Related solicitation 36C25724Q0640.

CTX QUANTIFERON SUPPLIES IDIQ - ADD EO 14398

Incumbent footprint

Public record

Qiagen, LLC$19.5M obligated across 397 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($19.5M) · all agencies · Top 4 shown (93%); remaining ~7% is other agencies.
Department of Health and Human Services (HHS)$6.1M · 31%Department of Defense (DOD)$5.4M · 28%Department of Veterans Affairs (VA)$4.7M · 24%Department of Justice (DOJ)$2.0M · 10%
Open full company profile

Related awards

Same incumbent
75F40121P00351
INGENUITY PATHWAY ANALYSIS MATCH CL LICENSE
$156K
Aug 21, 2026
75N90026P00032
26-001829 QIAGEN LLC STANDING ORDER FOR FY2026, 4 SHIPMENTS AS SPECIFIED IN THE PRICE QUOT…
$114K
Sep 1, 2026
W81XWH21P0169
CLC GENOMICS WB, NETWORK PLUS
$1.1M
Sep 27, 2026
36C24822P1535
EXERCISE OPTION YEAR 1, FUNDED
$491K
Sep 30, 2026
15F06726F0000329
QIAGEN CONSUMABLES
$245K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25725D0009?

36C25725D0009 (CTX quantiferon supplies IDIQ - ADD) is a 257-Network Contract Office 17 (36C257) award with an estimated value of —, currently held by Qiagen, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-25-D-0009?

36C257-25-D-0009 is the dashed form of PIID 36C25725D0009 (CTX quantiferon supplies IDIQ - ADD), held by Qiagen, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25725D0009?

257-Network Contract Office 17 (36C257) awarded 36C25725D0009 to Qiagen, LLC.

Who is the incumbent on 36C25725D0009?

Qiagen, LLC is the incumbent with $19.5M across 397 related awards in SCOUT’s public footprint.

When does Qiagen, LLC’s 36C25725D0009 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25725D0009